DAY 6 — VTE risk scoring — count before you reach for LMWH

Before you start low‑molecular‑weight heparin (LMWH) in pregnancy, you must assess VTE risk systematically. This concise MRCOG Part 2 revision explains why risk scoring comes first, how to apply a structured prevention pathway in exam and clinical scenarios, and which factors change your management plan. What you’ll learn: •The rationale: why risk assessment precedes treatment. •Common VTE risk scoring tools and key risk factors in pregnancy and postpartum. •When to give antenatal or postnatal LMWH, and when to provide mechanical prophylaxis instead. •How to weigh temporary risks (eg. hospital admission, C‑section) versus permanent risk factors. •Exam-focused approach: how to present a clear prevention plan in SBA/SAQ/viva. Who this is for: •MRCOG Part 2 candidates preparing for exam scenarios. •O&G trainees and clinicians revising thromboprophylaxis in pregnancy. •Medical students and exam-focused learners needing a structured VTE pathway. 👉 Register Now for MRCOG PART 2 Free Webinar: https://study-mrcog.com/events/?utm_s... Like, save for revision, and tag a colleague preparing for MRCOG. Comment the risk factor you find hardest to weigh — we’ll pin the clearest explanation. Resources & further reading: •Check the latest RCOG or national thromboprophylaxis guidelines for specific scoring tools and dosing. •Related topics: management of suspected VTE in pregnancy, LMWH dosing in renal impairment, antenatal care after prior VTE. #VTE #LMWH #Thromboprophylaxis #MRCOG #StudyMEDIC #Obstetrics #ExamRevision #PregnancyCare #VTErisk #MedicalEducation